Fatty liver affects 1 in 3 adults globally

24-Jul-2026

.

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), formerly non-alcoholic fatty liver disease, affects one in three adults globally and is linked to diabetes and cardiovascular risks. 

Often symptomless until advanced, early detection is crucial to prevent irreversible liver damage. Traditional liver biopsy is invasive, but new non-invasive imaging like ultrasound elastography can assess liver fibrosis efficiently and repeatedly.

 Advances in automated imaging promise faster, standardized evaluations, supporting a shift from treating late-stage disease to proactive screening and prevention amid rising metabolic health issues worldwide.